CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows provided by operating activities:
Net income	$ 1,799	$ 2,829
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of deferred issuance costs and fees	3	34
Earnings of equity method investments	(787)	(377)
Noncash credit loss expense	(2)	102
Noncash lease expense	162	159
Depreciation and amortization	141	120
Deferred taxes	478	816
Stock-based compensation expense	228	179
Changes in operating assets and liabilities:
Accounts receivable	347	(322)
Inventory – equipment	339	1,127
Other current assets	(39)	(26)
Accounts payable and accrued liabilities	(2,674)	(687)
Payables to sellers	1,841	5,145
Lease liabilities	(160)	(154)
Net cash provided by operating activities	1,676	8,945
Cash flows from investing activities:
Investment in notes receivable	(2,256)	(13,221)
Payments received on notes receivable	2,520	1,071
Cash received on transfer of notes receivable to partners	0	4,613
Investment in equity method investments	(193)	(512)
Return of investment in equity method investments	1,283	975
Cash distributions from equity method investments	787	377
Purchase of property and equipment	(22)	(89)
Net cash provided by (used in) investing activities	2,119	(6,786)
Cash flows from financing activities:
Proceeds from debt payable to third parties	0	3,400
Repayment of debt payable to third parties	(422)	(2,403)
Proceeds from issuance of common stock from stock option awards	0	5
Payments of tax withholdings related to issuance of restricted common stock and stock option awards	(75)	(95)
Net cash (used in) provided by financing activities	(497)	907
Net increase in cash and cash equivalents	3,298	3,066
Cash and cash equivalents as of beginning of period	12,279	12,667
Cash and cash equivalents as of end of period	15,577	15,733
Supplemental cash flow information:
Cash paid for taxes	(1)	0
Cash paid for interest	$ 92	$ 49